Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

QUERCETIN DIHYDRATE CRS (25 MG)

QUERCETIN DIHYDRATE CRS (25 MG)

6151-25-3

DISCOVER
GINKGOLIC ACIDS CRS (50 MG)

GINKGOLIC ACIDS CRS (50 MG)

NA

DISCOVER
SPANISH SAGE OIL FOR PEAK IDENTIFICATION CRS (250 MG)

SPANISH SAGE OIL FOR PEAK IDENTIFICATION CRS (250 MG)

8016-65-7

DISCOVER
GINKGO DRY EXTRACT FOR PEAK IDENTIFICATION CRS (150 MG)

GINKGO DRY EXTRACT FOR PEAK IDENTIFICATION CRS (150 MG)

NA

DISCOVER
FERULIC ACID CRS (20 MG)

FERULIC ACID CRS (20 MG)

537-98-4

DISCOVER
AMPHOTERICIN B FOR PEAK IDENTIFICATION CRS (10 MG)

AMPHOTERICIN B FOR PEAK IDENTIFICATION CRS (10 MG)

1397-89-3

DISCOVER
NORFLOXACIN FOR SYSTEM SUITABILITY CRS (10 MG)

NORFLOXACIN FOR SYSTEM SUITABILITY CRS (10 MG)

70458-96-7

DISCOVER
BENZANILIDE CRS (25 MG)

BENZANILIDE CRS (25 MG)

ND

DISCOVER
METHYLPHENIDATE HYDROCHLORIDECRS - * NARC (40 MG)

METHYLPHENIDATE HYDROCHLORIDECRS - * NARC (40 MG)

298-59-9

DISCOVER
CISPLATIN IMPURITY A CRS (15 MG)

CISPLATIN IMPURITY A CRS (15 MG)

14913-33-8

DISCOVER
CISPLATIN IMPURITY B CRS (15 MG)

CISPLATIN IMPURITY B CRS (15 MG)

NA

DISCOVER
IOPROMIDE CRS (100 MG)

IOPROMIDE CRS (100 MG)

73334-07-3

DISCOVER